Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001366683.2(DOCK9):c.1301C>T(p.Ala434Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0437 in 1,613,954 control chromosomes in the GnomAD database, including 1,873 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
DOCK9 (HGNC:14132): (dedicator of cytokinesis 9) Enables cadherin binding activity. Predicted to be involved in positive regulation of GTPase activity. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022]
DOCK9 Gene-Disease associations (from GenCC):
keratoconus
Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0022068322).
BP6
Variant 13-98902367-G-A is Benign according to our data. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-98902367-G-A is described in CliVar as Benign. Clinvar id is 402794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0769 is higher than 0.05.
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -